184
Participants
Start Date
June 1, 2024
Primary Completion Date
February 20, 2025
Study Completion Date
February 28, 2025
CPLE
It will be a double-blind study,CPLE and Placebo will be marked as either Group A or Group B.Half of the patients will receive Group A and other half will receive Group B drug along with standard treatment according to national guideline,Each participant will receive either CPLE or Placebo,500 mg 2 capsules three times daily for 5 days and will be followed up daily upto study day 5.
Placebo
"The patients will be assigned to visually matched placebo 2 capsule t.i.d for 5 days The oral capsule of CPLE and placebo will be provided by the Institute of Technology Transfer and Innovation (ITTI), an institute in Bangladesh Council of Scientific and Industrial Research (BCSIR). On receipt, the medications will be stored in a secure area at room temperature. Enrolled patients will receive CPLE or placebo for 5 days.~Clinical data will be captured on structured case report forms."
Prof Shohael Mahmud Arafat, Dhaka
Institute of Technology Transfer & Innovation (ITTI)
UNKNOWN
Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh
OTHER